Terns Pharmaceuticals's total assets for Q4 2025 were $1.03B, an increase of 239.82% from the previous quarter. TERN total liabilities were $18.55M for the fiscal quarter, a 5.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.